1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Global Breast Cancer Screening Market – By Test Type

1.3.2        Global Breast Cancer Screening Market – By End User

1.3.3        Europe Breast Cancer Screening Market– By Region

2.           Breast Cancer Screening Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Breast Cancer Screening – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe

4.3         Expert Opinion

5.           Europe Breast Cancer Screening Market – Industry Dynamics

5.1         Key Drivers

5.1.1        Growing Breast Cancer Cases

5.1.2        Growing Initiatives for Breast Cancer Management

5.2         Key Market Restraints

5.2.1        High Cost Associated With Breast Cancer Screening

5.3         Key Market Opportunities

5.3.1        Product Launches Along With The Technological Advancements In Breast Imaging Modalities

5.4         Future Trends

5.4.1        Growing Agreements  And Collaborations For Diagnostic Solutions

5.5         Impact Analysis

6.           Breast Cancer Screening Market – Regional Analysis

6.1         Europe Breast Cancer Screening Market Revenue Forecast And Analysis

6.2         Market Positioning of Key Players

7.           Breast Cancer Screening Market Analysis –  By Test Type

7.1         Overview

7.2         Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)

7.2.1        Europe Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

7.3         Blood Marker Test

7.3.1        Overview

7.4         Blood Marker Tests: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Imaging Test

7.5.1        Overview

7.5.2        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

7.6         Genetic Test

7.6.1        Overview

7.6.2        Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.7         Immunohistochemistry Test

7.7.1        Overview

7.7.2        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.           Breast Cancer Screening Market – By End User

8.1         Overview

8.2         Breast Cancer Screening Market, by End User, 2019 and 2027 (%)

8.2.1        Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostics Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Research Laboratories

8.5.1        Overview

8.6         Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.7         Cancer Institutes

8.7.1        Overview

8.8         Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

9.           Breast Cancer Screening Market– Regional Analysis

9.1         Europe: Breast Cancer Screening Market

9.1.1        Overview

9.1.2        Europe: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        Europe: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.4        Europe: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.5        Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

9.1.6        Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Germany: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.6.3          Germany: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.7        UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          UK: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.7.3          UK: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.8        France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          France: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.8.3          France: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.9        Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          Spain: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.9.3          Spain: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.10     Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Italy: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.10.3       Italy: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

10.        Impact of COVID-19 Pandemic On Europe Breast Cancer Screening Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Breast Cancer Screening Market – Industry Landscape

11.1      Overview

11.2      Growth Strategies in The Breast Cancer Screening Market, 2016-2020

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Breast Cancer Screening Market – Key Company Profiles

12.1      General Electric Company

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Siemens Healthineers AG

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Exact Sciences Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Koninklijke Philips N.V.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      BD

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Myriad Genetics, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Oncocyte Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Danaher

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   POC Medical Systems

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.             France Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Spain Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Spain Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Italy Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Italy Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 15.          Recent Inorganic Growth Strategies In The Breast Cancer Screening Market

Table 16.          Recent Organic Growth Strategies In The Breast Cancer Screening Market

Table 17.          Glossary of Terms, Breast Cancer Screening Market

LIST OF FIGURES

Figure 1.           Breast Cancer Screening Market Segmentation

Figure 2.           Breast Cancer Screening Segmentation – By Region

Figure 3.           Europe Breast Cancer Screening Market Overview

Figure 4.           The Imaging Test Segment Held Largest Share Of Test Type Segment In Breast Cancer Screening Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Breast Cancer Screening Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Breast Cancer Screening Market Impact Analysis Of Driver And Restraints

Figure 9.           Europe Breast Cancer Screening Market – Revenue Forecast And Analysis – 2019- 2027

Figure 10.        Market Positioning Of Key Players In Breast Cancer Screening Market

Figure 11.        Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)

Figure 12.        Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Breast Cancer Screening Market, by End User, 2019 and 2027 (%)

Figure 17.        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Europe: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 22.        Europe Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 23.        Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

Figure 24.        Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic In European Country Markets

Figure 30.        Growth Strategies in The Breast Cancer Screening Market, 2016-2020